TB-500
Péptido de investigación asociado con reparación tisular y recuperación
Product Specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
Thymosin Beta-4 (TB-500) se presenta como un péptido de investigación asociado con la reparación de tejidos, la regeneración, la cicatrización de heridas y aplicaciones relacionadas con la recuperación. El producto está destinado únicamente a investigación científica y no es para uso diagnóstico, terapéutico o de consumo humano.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
🇪🇺 EU & UK Shipped • Free over €300 • 2-5 Business Days
Frequently asked questions
- TB-500 is a synthetic 17-amino-acid fragment derived from the central actin-binding region of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein found in most mammalian cells. The fragment retains the conserved LKKTET actin-binding motif. Molecular weight is approximately 2.0-2.2 kDa depending on terminal modifications.
- Each batch is HPLC-verified at ≥99% purity, with mass spectrometry confirming the molecular identity. A Certificate of Analysis is included with every shipment.
- Lyophilised TB-500 is stable at -20 °C in a sealed, desiccant-protected vial for long-term storage. Reconstituted solutions are less stable — single-use aliquots are recommended to avoid freeze-thaw cycles, which can degrade the peptide.
- TB-500 (and full-length Tβ4) has been studied in preclinical models of skin wound healing, corneal repair, myocardial infarction, skeletal muscle injury, and central nervous system damage. The mechanism of interest is G-actin sequestration and downstream effects on cell migration.
- No. TB-500 is not approved by FDA, EMA, or any other regulator for human or veterinary use. WADA classifies it under the S0 Non-Approved Substances category. It is supplied for laboratory research only.
